NIAID Banner Logo Image

Mycobacterium Citations List: April, 2018

Literature Citations

1. Synthesis and Evaluation of 4',5'-Dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] Analogues against Both Active and Dormant Mycobacterium tuberculosis. Alluri, K.K., R.S. Reshma, R. Suraparaju, S. Gottapu, and D. Sriram. Bioorganic & Medicinal Chemistry, 2018. 26(8): p. 1462-1469. PMID[29501415].
[PubMed]. TB_04_2018.

2. Investigating the Inhibitory Potential of 2-Aminopurine Metal Complexes against Serine/Threonine Protein Kinases from Mycobacterium tuberculosis. Bais, V.S., B. Mohapatra, N. Ahamad, S. Boggaram, S. Verma, and B. Prakash. Tuberculosis, 2018. 108: p. 47-55. PMID[29523327].
[PubMed]. TB_04_2018.

3. Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.Bakula, Z., M. Modrzejewska, L. Pennings, M. Proboszcz, A. Safianowska, J. Bielecki, J. van Ingen, and T. Jagielski. Antimicrobial Agents and Chemotherapy, 2018. 62(4): e01788-01717. PMID[29437627].
[PubMed]. TB_04_2018.

4. Synthesis and Antimicrobial Activity of Some 5-Chloro-3-phenyl-1H-indole-2-carbonyl azide Derivatives.Basavarajaiah, S.M. and B.H.M. Mruthyunjayaswamy. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2018. 57(3): p. 390-399. ISI[000428228600008].
[WOS]. TB_04_2018.

5. Synthesis and Antimycobacterial Evaluation of New (2-Oxo-2H-chromen-3-yl) Substituted Fluoroquinolones.Charushin, V.N., N.N. Mochulskaya, F.V. Antipin, S.K. Kotovskaya, E.V. Nosova, M.A. Ezhikova, M.I. Kodess, and M.A. Kravchenko. Journal of Fluorine Chemistry, 2018. 208: p. 15-23. ISI[000427336600003].
[WOS]. TB_04_2018.

6. Synthesis, Antimycobacterial Evaluation, and QSAR Analysis of meso-Dihydroguaiaretic acid Derivatives.Chavez-Villarreal, K.G., A. Garcia, A. Romo-Mancillas, E. Garza-Gonzalez, N. Waksman de Torres, L.D. Miranda, R.E. Moo-Puc, J. Chale-Dzul, and M. del Rayo Camacho-Corona. Medicinal Chemistry Research, 2018. 27(4): p. 1026-1042. ISI[000427629900002].
[WOS]. TB_04_2018.

7. Conformationally Constrained Cinnolinone nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis. Dawadi, S., H.I.M. Boshoff, S.W. Park, D. Schnappinger, and C.C. Aldrich. ACS Medicinal Chemistry Letters, 2018. 9(4): p. 386-391. PMID[29670706]. PMCID[PMC5900334].
[PubMed]. TB_04_2018.

8. Potent Inhibitors of Mycobacterium tuberculosis Growth Identified by Using In-cell NMR-based Screening.DeMott, C.M., R. Girardin, J. Cobbert, S. Reverdatto, D.S. Burz, K. McDonough, and A. Shekhtman. ACS Chemical Biology, 2018. 13(3): p. 733-741. PMID[29359908]. PMCID[PMC5856640].
[PubMed]. TB_04_2018.

9. Survey on Medicinal Plants Traditionally Used in Senegal for the Treatment of Tuberculosis (Tb) and Assessment of Their Antimycobacterial Activity. Diop, E.A., E.F. Queiroz, S. Kicka, S. Rudaz, T. Diop, T. Soldati, and J.L. Wolfender. Journal of Ethnopharmacology, 2018. 216: p. 71-78. PMID[29289797].
[PubMed]. TB_04_2018.

10. Synthesis and Evaluation of Some Novel 2-Amino-4-aryl thiazoles for Antitubercular Activity. Gundlewad, G.B. and B.R. Patil. Journal of Heterocyclic Chemistry, 2018. 55(3): p. 769-774. ISI[000427479900023].
[WOS]. TB_04_2018.

11. Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment. Halicki, P.C.B., L.A. Ferreira, K.C.G. De Moura, P.F. Carneiro, K.P. Del Rio, T. Carvalho, M. Pinto, P.E.A. da Silva, and D.F. Ramos. Frontiers in Microbiology, 2018. 9(673): 7pp. PMID[29686657]. PMCID[PMC5900025].
[PubMed]. TB_04_2018.

12. Synthesis and Inhibition Studies of Substrate and Suicide Analogs for Mycobacterium tuberculosis for Trehalose phosphate phosphatase (TPP2). Kapil, S., S. Sucheck, D. Ronning, and S. Thanna. Abstracts of Papers of the American Chemical Society, 2017. 254. ISI[000429525601494].
[WOS]. TB_04_2018.

13. An Efficient Green Synthesis of Some Functionalized Spiro Chromene Based Scaffolds as Potential Antitubercular Agents. Khan, G.A., G.A. Naikoo, J.A. War, I.A. Sheikh, U.J. Pandit, I. Khan, A.K. Harit, and R. Das. Journal of Heterocyclic Chemistry, 2018. 55(3): p. 699-708. ISI[000427479900014].
[WOS]. TB_04_2018.

14. The 7-Phenyl benzoxaborole Series Is Active against Mycobacterium tuberculosis. Korkegian, A., T. O'Malley, Y. Xia, Y. Zhou, D.S. Carter, B. Sunde, L. Flint, D. Thompson, T.R. Ioerger, J. Sacchettini, M.R.K. Alley, and T. Parish. Tuberculosis, 2018. 108: p. 96-98. PMID[29523334]. PMCID[PMC5854369].
[PubMed]. TB_04_2018.

15. Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.Krause, M., H. Foks, E. Augustynowicz-Kopec, A. Napiorkowska, M. Szczesio, and K. Gobis. Molecules, 2018. 23(4): E985. PMID[29690646].
[PubMed]. TB_04_2018.

16. Synthesis, Biological Evaluation, and Metabolic Stability of Phenazine Derivatives as Antibacterial Agents.Krishnaiah, M., N.R. de Almeida, V. Udumula, Z. Song, Y.S. Chhonker, M.M. Abdelmoaty, V.A. do Nascimento, D.J. Murry, and M. Conda-Sheridan. European Journal of Medicinal Chemistry, 2018. 143: p. 936-947. PMID[29227933].
[PubMed]. TB_04_2018.

17. Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis. Lentz, F., N. Reiling, A. Martins, J. Molnar, and A. Hilgeroth. Molecules, 2018. 23(4): E825. PMID[29617279].
[PubMed]. TB_04_2018.

18. 1H-1,2,3-Triazole-tethered Isatin-Coumarin Hybrids: Design, Synthesis and in Vitro Anti-mycobacterial Evaluation.Liu, B., G. Hu, X. Tang, G. Wang, and Z. Xu. Journal of Heterocyclic Chemistry, 2018. 55(3): p. 775-780. ISI[000427479900024].
[WOS]. TB_04_2018.

19. Lipase-catalyzed Kinetic Resolution of Novel Antitubercular Benzoxazole Derivatives. Lukowska-Chojnacka, E., A. Kowalkowska, and A. Napiorkowska. Chirality, 2018. 30(4): p. 457-468. PMID[29274237].
[PubMed]. TB_04_2018.

20. Cementoin-SLPI Fusion Protein Binds to Human Monocytes and Epithelial Cells and Shows Higher Biological Activity Than SLPI. Maffia, P.C., D. Guerrieri, X. Villalonga, F. Caro, S. Gomez, N. Tateosian, B.P. Bogado, M.L. Sanchez, N. Ambrosi, and E. Chuluyan. Scientific Reports, 2018. 8(5332): 10pp. PMID[29593284]. PMCID[PMC5871749].
[PubMed]. TB_04_2018.

21. Synthesis and Antimycobacterial Activity of Triterpenic A-ring Azepanes. Medvedeva, N.I., O.B. Kazakova, T.V. Lopatina, I.E. Smirnova, G.n.V. Giniyatullina, I.P. Baikova, and V.E. Kataev. European Journal of Medicinal Chemistry, 2018. 143: p. 464-472. PMID[29202408].
[PubMed]. TB_04_2018.

22. An Allosteric Inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a Novel Combinatorial Therapy. Mishra, A., A.S. Mamidi, R.S. Rajmani, A. Ray, R. Roy, and A. Surolia. EMBO Molecular Medicine, 2018. 10(4): e8038. PMID[29483133]. PMCID[PMC5887547].
[PubMed]. TB_04_2018.

23. Evaluation of Isoprinosine to be Repurposed as an Adjunct Anti-tuberculosis Chemotherapy. Mishra, A.K., S.M. Yabaji, and R.K. Dubey. Medical Hypotheses, 2018. 115: p. 77-80. PMID[29685203].
[PubMed]. TB_04_2018.

24. Pharmacophoric Screening of Newly Synthesized Isoniazid Derivatives and Their Antimycobacterial Activity. Naeem, S., S. Akhtar, Z. Ali, M.Y. Noori, and A. Ahmed. Pakistan Journal of Pharmaceutical Sciences, 2018. 31(2): p. 567-573. PMID[29618449].
[PubMed]. TB_04_2018.

25. Activity-based Classification Circumvents Affinity Prediction Problems for Pyrrolidine carboxamide Inhibitors of InhA. Narkhede, Y., B. Merget, S. Wagner, and C. Sotriffer. Journal of Molecular Graphics & Modelling, 2018. 80: p. 76-84. PMID[29328993].
[PubMed]. TB_04_2018.

26. Cyclophostin and Cyclipostins Analogues, New Promising Molecules to Treat Mycobacterial-related Diseases.Nguyen, P.C., A. Madani, P. Santucci, B.P. Martin, R.R. Paudel, S. Delattre, J.L. Herrmann, C.D. Spilling, L. Kremer, S. Canaan, and J.F. Cavalier. International Journal of Antimicrobial Agents, 2018. 51(4): p. 651-654. PMID[29241819].
[PubMed]. TB_04_2018.

27. Synthesis and Biological Evaluation of Some Bicyclic 2-(2,4-dimethylphenylthio)phenyl aniline and Its Amide Derivatives as Potential Antitubercular Agents. Patil, Y., R. Shingare, S. Chakraborty, R. Borkute, D. Sarkar, and B. Madje. Journal of Chemical Sciences, 2018. 130(3): p. 22. ISI[000427304500002].
[WOS]. TB_04_2018.

28. Antimycobacterial Potential of the Juniper Berry Essential Oil in Tap Water. Peruc, D., I. Gobin, M. Abram, D. Broznic, T. Svalina, S. Stifter, M.M. Staver, and B. Ticac. Arhiv Za Higijenu Rada I Toksikologiju, 2018. 69(1): p. 46-54. PMID[29604199].
[PubMed]. TB_04_2018.

29. Dipeptidyl boronates as ClpP1P2 Inhibitors: A Novel Approach to Anti Tuberculosis Therapy. Poulsen, A., P. Gopal, S. Santhanakrishnan, K.F. Jihao, C. Huang, B.C.S. Chia, Y. Qiu, U. Lakshmanan, M. Li, J.P. Sarathy, W. Moreira, C.B. Low, M. Gengenbacher, K. Sangthongpitag, T. Keller, B. Dymock, and T. Dick. Abstracts of Papers of the American Chemical Society, 2017. 254. ISI[000429556701395].
[WOS]. TB_04_2018.

30. Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.Prati, F., F. Zuccotto, D. Fletcher, M.A. Convery, R. Fernandez-Menendez, R. Bates, L. Encinas, J. Zeng, C.W. Chung, P. De Dios Anton, A. Mendoza-Losana, C. Mackenzie, S.R. Green, M. Huggett, D. Barros, P.G. Wyatt, and P.C. Ray. ChemMedChem, 2018. 13(7): p. 672-677. PMID[29399991]. PMCID[PMC5915743].
[PubMed]. TB_04_2018.

31. Molecular Modeling Studies and in Vitro Screening of Dihydrorugosaflavonoid and Its Derivatives against Mycobacterium tuberculosis. Puranik, N.V., P. Srivastava, S. Swami, A. Choudhari, and D. Sarkar. RSC Advances, 2018. 8(19): p. 10634-10643. ISI[000428581000033].
[WOS]. TB_04_2018.

32. A High Throughput Methodology for Susceptibility Testing of Mycobacterium tuberculosis Isolates. Rampersad, T., M. Makume, P. Sobia, and A.W. Sturm. Journal of Microbiological Methods, 2018. 146: p. 64-67. PMID[29410256].
[PubMed]. TB_04_2018.

33. Synthesis and Evaluation of Novel Coumarin-Oxime Ethers as Potential Anti-tubercular Agents: Their DNA Cleavage Ability and BSA Interaction Study. Reddy, D.S., M. Kongot, S.P. Netalkar, M.M. Kurjogi, R. Kumar, F. Avecilla, and A. Kumar. European Journal of Medicinal Chemistry, 2018. 150: p. 864-875. PMID[29597169].
[PubMed]. TB_04_2018.

34. Quercetin 3-O-Glucoside Recovered from the Wild Egyptian Sahara Plant, Euphorbia paralias L., Inhibits Glutamine Synthetase and Has Antimycobacterial Activity. Safwat, N.A., M.T. Kashef, R.K. Aziz, K.F. Amer, and M.A. Ramadan. Tuberculosis, 2018. 108: p. 106-113. PMID[29523309].
[PubMed]. TB_04_2018.

35. Synthesis of 2,3-Dihydro flavone coumarins as a Class of Potent Antifungal and Anti-inflammatory Agents.Shaikh, F., S. Shastri, B.M. Chougala, M. Holiyachi, L.A. Shastri, S.D. Joshi, and V.A. Sunagar. ChemistrySelect, 2018. 3(12): p. 3451-3458. ISI[000429418000014].
[WOS]. TB_04_2018.

36. Synthesis, Biological Evaluation and Docking Study of Some Novel Isoxazole Clubbed 1,3,4-Oxadiazoles Derivatives.Shingare, R.M., Y.S. Patil, J.N. Sangshetti, R.B. Patil, D.P. Rajani, and B.R. Madje. Medicinal Chemistry Research, 2018. 27(4): p. 1283-1291. ISI[000427629900024].
[WOS]. TB_04_2018.

37. Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate kinase Inhibitors. Song, L., R. Merceron, B. Gracia, A.L. Quintana, M.D.P. Risseeuw, F. Hulpia, P. Cos, J.A. Ainsa, H. Munier-Lehmann, S.N. Savvides, and S. Van Calenbergh. Journal of Medicinal Chemistry, 2018. 61(7): p. 2753-2775. PMID[29510037].
[PubMed]. TB_04_2018.

38. Antitubercular bis-Substituted cyclam Derivatives: Structure-Activity Relationships and in Vivo Studies.Spain, M., J.K. Wong, G. Nagalingam, J.M. Batten, E. Hortle, S.H. Oehlers, X.F. Jiang, H.E. Murage, J.T. Orford, P. Crisologo, J.A. Triccas, P.J. Rutledge, and M.H. Todd. Journal of Medicinal Chemistry, 2018. 61(8): p. 3595-3608. PMID[29558124].
[PubMed]. TB_04_2018.

39. Synthesis and Antimycobacterial Activity of 1-(beta-D-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole. Srivastava, S., D. Bimal, K. Bohra, B. Singh, P. Ponnan, R. Jain, M. Varma-Basil, J. Maity, M. Thirumal, and A.K. Prasad. European Journal of Medicinal Chemistry, 2018. 150: p. 268-281. PMID[29529504].
[PubMed]. TB_04_2018.

40. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships. Straniero, V., C. Zanotto, L. Straniero, A. Casiraghi, S. Duga, A. Radaelli, C.D.G. Morghen, and E. Valoti. ChemMedChem, 2017. 12(16): p. 1303-1318. PMID[28586174].
[PubMed]. TB_04_2018.

41. Biological Evaluation of New 2-Phenethylbenzoyl thiourea Derivatives as Antituberculosis Agents. Stratan, E., N. Turcan, V. Crudu, E. Romancenco, T. Cotelea, G.M. Nitulescu, C. Chirita, and L. Morusciag. Farmacia, 2018. 66(1): p. 97-106. ISI[000429408600013].
[WOS]. TB_04_2018.

42. Structure-Activity Relationships for Analogs of the Tuberculosis Drug Bedaquiline with the Naphthalene Unit Replaced by Bicyclic Heterocycles. Sutherland, H.S., A.S.T. Tong, P.J. Choi, D. Conole, A. Blaser, S.G. Franzblau, C.B. Cooper, A.M. Upton, M.U. Lotlikar, W.A. Denny, and B.D. Palmer. Bioorganic & Medicinal Chemistry, 2018. 26(8): p. 1797-1809. PMID[29482950]. PMCID[PMC5933462].
[PubMed]. TB_04_2018.

43. Evaluation of Triazole and Isoxazole Derivatives as Potential Anti-infective Agents. Tarawneh, A.H., L.a.A. Al-Momani, F. Leon, S.K. Jain, A.V. Gadetskaya, S.T. Abu-Orabi, B.L. Tekwani, and S.J. Cutler. Medicinal Chemistry Research, 2018. 27(4): p. 1269-1275. ISI[000427629900022].
[WOS]. TB_04_2018.

44. Fragment-based Approach to Targeting Inosine-5'-monophosphate dehydrogenase (IMPDH) from Mycobacterium tuberculosis. Trapero, A., A. Pacitto, V. Singh, M. Sabbah, A.G. Coyne, V. Mizrahi, T.L. Blundell, D.B. Ascher, and C. Abell. Journal of Medicinal Chemistry, 2018. 61(7): p. 2806-2822. PMID[29547284]. PMCID[PMC5900554].
[PubMed]. TB_04_2018.

45. New Lipophilic Isoniazid Derivatives and Their 1,3,4-Oxadiazole Analogues: Synthesis, Antimycobacterial Activity and Investigation of Their Mechanism of Action. Vosatka, R., M. Kratky, M. Svarcova, J. Janousek, J. Stolarikova, J. Madacki, S. Huszar, K. Mikusova, J. Kordulakova, F. Trejtnar, and J. Vinsova. European Journal of Medicinal Chemistry, 2018. 151: p. 824-835. PMID[29679902].
[PubMed]. TB_04_2018.

46. Design and Synthesis of 2-Amino-thiophene-tethered ureidopenicillin Analogs with Potent Antibacterial and Antitubercular Activity. Wagh, M.A., S.B. Baravkar, G.S. Jedhe, R. Borkute, A.S. Choudhari, D. Sarkar, and G.J. Sanjayan. ChemistrySelect, 2018. 3(11): p. 3122-3126. ISI[000428379500032].
[WOS]. TB_04_2018.

47. Synthesis, Evaluation and CoMFA/CoMSIA Study of Nitrofuranyl methyl N-heterocycles as Novel Antitubercular Agents. Wang, A., Y. Yang, Y. Jun, B. Wang, K. Lv, M. Liu, H. Guo, and Y. Lu. Bioorganic & Medicinal Chemistry, 2018. 26(8): p. 2073-2084. PMID[29551372].
[PubMed]. TB_04_2018.

48. Reagent Controlled Stereoselective Synthesis of alpha-Glucans. Wang, L., H.S. Overkleeft, G.A. van der Marel, and J.D.C. Codee. Journal of the American Chemical Society, 2018. 140(13): p. 4632-4638. PMID[29553729]. PMCID[PMC5890317].
[PubMed]. TB_04_2018.

49. Synthesis of FR900098 Analogs as Inhibitors of Plasmodium falciparum and Mycobacterium tuberculosis 1-Deoxy-D-xylulose-5-phosphate reductoisomerase (DXR). Wang, R., R. Edwards, A. Haymond, H. Boshoff, A. Odom, R. Couch, and C. Dowd. Abstracts of Papers of the American Chemical Society, 2017. 254. ISI[000429556701440].
[WOS]. TB_04_2018.

50. Structures of the Mycobacterium tuberculosis GlpX Protein (Class II Fructose-1,6-bisphosphatase): Implications for the Active Oligomeric State, Catalytic Mechanism and Citrate Inhibition.Wolf, N.M., H.J. Gutka, F. Movahedzadeh, and C. Abad-Zapatero. Acta Crystallographica Section D-Structural Biology, 2018. 74(Pt 4): p. 321-331. PMID[29652259]. PMCID[PMC5892879].
[PubMed]. TB_04_2018.

51. Identification of a New Series of Benzothiazinone Derivatives with Excellent Antitubercular Activity and Improved Pharmacokinetic Profiles. Xiong, L., C. Gao, Y.J. Shi, X. Tao, J. Rong, K.L. Liu, C.T. Peng, N.Y. Wang, Q. Lei, Y.W. Zhang, L.T. Yu, and Y.Q. Wei. RSC Advances, 2018. 8(20): p. 11163-11176. ISI[000429534200054].
[WOS]. TB_04_2018.

52. Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs against Mycobacterium tuberculosis. Xu, Y., L. Wang, M.D. Zimmerman, K.Y. Chen, L. Huang, D.J. Fu, F. Kaya, N. Rakhilin, E.V. Nazarova, P. Bu, V. Dartois, D.G. Russell, and X. Shen. Plos Pathogens, 2018. 14(4): e1006974. PMID[29698476].
[PubMed]. TB_04_2018.

53. Synthesis, Characterization and Cell Imaging Properties of Rare Earth Compounds Based on Hydroxamate Ligand.Yang, L., Y. Zhang, L. Hu, Y. Zong, R. Zhao, T. Jin, and W. Gu. Journal of Rare Earths, 2018. 36(4): p. 418-423. ISI[000429309700015].
[WOS]. TB_04_2018.

54. Diterpenoids from the Roots of Euphorbia ebracteolata and Their Anti-tuberculosis Effects. Yu, Z., Y. Wei, X. Tian, Q. Yan, Q. Yan, X. Huo, C. Wang, C. Sun, B. Zhang, and X. Ma. Bioorganic Chemistry, 2018. 77: p. 471-477. PMID[29453078].
[PubMed]. TB_04_2018.

55. Family-wide Analysis of Aminoacyl-sulfamoyl-3-deazaadenosine Analogues as Inhibitors of Aminoacyl-tRNA synthetases. Zhang, B., S. De Graef, M. Nautiyal, L. Pang, B. Gadakh, M. Froeyen, L. Van Mellaert, S.V. Strelkov, S.D. Weeks, and A. Van Aerschot. European Journal of Medicinal Chemistry, 2018. 148: p. 384-396. PMID[29477072].
[PubMed]. TB_04_2018.

Patent Citations

56. Preparation of bis-Indolyl pyrazines for the Treatment of Bacterial Infections. Mueller, T.J.J., G. Sommer, B.O.A. Tasch, R. Kalscheuer, and N. Rehberg. Patent. 2018. 2016-191804 3301096: 26pp.
[Patent]. TB_04_2018.

57. Preparation of bis-Indolyl pyrazines for the Treatment of Bacterial Infections. Mueller, T.J.J., G. Sommer, B.O.A. Tasch, R. Kalscheuer, and N. Rehberg. Patent. 2018. 2017-EP74690 2018060367: 52pp.
[Patent]. TB_04_2018.

58. Preparation of Antibacterial Agents against D,D- and L,D-Transpeptidases. Townsend, C.A. and E. Lloyd. Patent. 2018. 2017-US55828 2018071358: 93pp.
[Patent]. TB_04_2018.

Database last updated: September 2018